Guided Therapeutics (GTHP) Accumulated Depreciation & Amortization (2019 - 2020)

Guided Therapeutics has disclosed Accumulated Depreciation & Amortization across 2 years of filings, most recently posting $1.7 million for Q4 2020.

• Accumulated Depreciation & Amortization for Q4 2020 came in at $1.7 million, down 27.04% year-over-year; the trailing twelve-month figure through Dec 2020 was $1.7 million (down 27.04% YoY), and the FY2020 annual result was $1.7 million, down 27.04% from the prior year.
• Accumulated Depreciation & Amortization came in at $1.7 million for Q4 2020 at Guided Therapeutics, down from $2.4 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.4 million in Q4 2019 to a low of $1.7 million in Q4 2020.